AR027519A1 - Purificacion de aceites de castor polioxietilados con carbon activado - Google Patents

Purificacion de aceites de castor polioxietilados con carbon activado

Info

Publication number
AR027519A1
AR027519A1 ARP010100257A ARP010100257A AR027519A1 AR 027519 A1 AR027519 A1 AR 027519A1 AR P010100257 A ARP010100257 A AR P010100257A AR P010100257 A ARP010100257 A AR P010100257A AR 027519 A1 AR027519 A1 AR 027519A1
Authority
AR
Argentina
Prior art keywords
activated carbon
polyoxyethyled
purification
castor oils
castor oil
Prior art date
Application number
ARP010100257A
Other languages
English (en)
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of AR027519A1 publication Critical patent/AR027519A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/10—Refining fats or fatty oils by adsorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Abstract

Aceites de castor polioxietilados producidos preparando una suspension de carbon activado y un aceite de castor polioxietilado y separando el carbonactivado del aceite de castor polioxietilado. También se revelan composiciones que contienen el aceite de castor tratado y un agente activo tal como un agentefarmacéutico.
ARP010100257A 2000-01-20 2001-01-19 Purificacion de aceites de castor polioxietilados con carbon activado AR027519A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17745900P 2000-01-20 2000-01-20

Publications (1)

Publication Number Publication Date
AR027519A1 true AR027519A1 (es) 2003-04-02

Family

ID=22648678

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100257A AR027519A1 (es) 2000-01-20 2001-01-19 Purificacion de aceites de castor polioxietilados con carbon activado

Country Status (8)

Country Link
US (1) US20060058541A1 (es)
EP (1) EP1251845A1 (es)
JP (1) JP2003520230A (es)
AR (1) AR027519A1 (es)
AU (1) AU776993B2 (es)
CA (1) CA2397848A1 (es)
CO (1) CO5271755A1 (es)
WO (1) WO2001052838A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005515187A (ja) * 2001-11-26 2005-05-26 スーパージェン インコーポレイテッド ポリオキシエチル化ひまし油を使用する医薬組成物の調製方法
AU2003256786B2 (en) * 2003-07-24 2010-01-07 Fresenius Kabi Oncology Limited Process for the purification of non-ionic solvents for stabilized injectable pharmaceutical formulations
US20050016926A1 (en) * 2003-07-24 2005-01-27 Dabur Research Foundation Stabilized formulation
WO2015005961A1 (en) 2013-07-12 2015-01-15 Emd Millipore Corporation A method of determining virus removal from a sample containing a target protein using activated carbon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2880292B2 (ja) * 1992-11-27 1999-04-05 ナプロ バイオセラピューティクス，インコーポレイテッド 注射可能組成物
US5925776A (en) * 1997-12-24 1999-07-20 Schein Pharmacetical, Inc. Polyethoxylated castor oil, process of making the same and formulations thereof
CA2347097C (en) * 1998-10-20 2009-06-16 Ben Venue Laboratories, Inc. Process for purification of solvents useful in the preparation of pharmaceutical compositions

Also Published As

Publication number Publication date
JP2003520230A (ja) 2003-07-02
WO2001052838A1 (en) 2001-07-26
CO5271755A1 (es) 2003-04-30
US20060058541A1 (en) 2006-03-16
AU3285801A (en) 2001-07-31
AU776993B2 (en) 2004-09-30
CA2397848A1 (en) 2001-07-26
EP1251845A1 (en) 2002-10-30

Similar Documents

Publication Publication Date Title
CR10408A (es) Composiciones novedosas para el trastornos del cabello y procedimiento de preparacion de las mismas
TNSN06071A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
BR0012752A (pt) Benzofuril piperazinas e benzofuril homopiperazinas: agonistas de serotonina
PA8514401A1 (es) Nuevos derivados de piperazina
ECSP077126A (es) Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores
BR0211905A (pt) Dialdeìdos de rapamicina
UY26885A1 (es) Activadores de la tetrazolil-fenil acetamido glucoquinasa
PE20081374A1 (es) Combinacion que comprende un agente antipsicotico y (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina
AR078283A1 (es) Formulaciones de suspension oral de dibenzazepina carboxamidas
CL2009001580A1 (es) Composicion oxidante que comprende 20ppm de dioxido de cloro, aniones oxicloro; y un segiundo agente oxidante que es un peroxido; donde la composicion comprende no mas de 0,25mg de aniones oxi-cloro por gramo de composicion.
AR005867A1 (es) Composiciones desinfectantes y procesos para desinfectar superficies
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
PA8576201A1 (es) Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco
AP2002002427A0 (en) Ppar compounds.
TNSN07240A1 (en) Compounds for flaviviridae treatment
AR082155A1 (es) Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido
CO4770892A1 (es) Composiciones desinfectantes y proceso para desinfectar su- perficies
NO20055002L (no) Benzol[1,2,5]tiadiazolforbindelser
AR027519A1 (es) Purificacion de aceites de castor polioxietilados con carbon activado
ATE497967T1 (de) Interzelluläre kommunikation erleichternden verbindungen und deren medizinischen verwendungen
ECSP045123A (es) Composición para catéteres y sus usos
AR023511A1 (es) Composicion que comprende (s) y (r) 5-amino-3-ciano-1-(2,6-dicloro-4-trifluorometilfenil)-4-trifluoro-metilsulfinilpirazol, dichos compuestos aislados y usos de los mismos como plaguicida
GEP20053590B (en) Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors
AR005970A1 (es) Compuestos de benzotiofeno y formulaciones farmaceuticas que los contienen como agente activo
AR047880A1 (es) COMBINACIoN DE UN INHIBIDOR DE RENINA Y DIURÉTICOS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal